EcoR1 Capital, LLC - Nov 6, 2024 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
10%+ Owner
Signature
/s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC
Stock symbol
TNGX
Transactions as of
Nov 6, 2024
Transactions value $
-$8,435,743
Form type
4
Date filed
11/8/2024, 07:24 PM
Previous filing
Aug 16, 2024
Next filing
Dec 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNGX Common Stock Sale -$4.9M -1.49M -11.21% $3.28 11.8M Nov 6, 2024 See Note F1, F2, F3
transaction TNGX Common Stock Sale -$205K -62.3K -0.53% $3.29 11.8M Nov 7, 2024 See Note F1, F4, F5
transaction TNGX Common Stock Sale -$3.33M -1.14M -9.71% $2.92 10.6M Nov 7, 2024 See Note F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Qualified Fund and Mr. Nodelman. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim ownership of such securities except to the extent of their respective pecuniary interests therein.
F2 Qualified Fund sold 1,406,529 of the shares sold in this transaction.
F3 After this transaction, Qualified Fund held 11,156,852 shares of Issuer's Common Stock.
F4 Qualified Fund sold 58,647 of the shares sold in this transaction.
F5 After this transaction, Qualified Fund held 11,098,205 shares of Issuer's Common Stock.
F6 Qualified Fund sold 1,075,794 of the shares sold in this transaction.
F7 After this transaction, Qualified Fund held 10,022,411 shares of Issuer's Common Stock.